New shot could tame stubborn high cholesterol
NCT ID NCT07223658
First seen Jun 24, 2026 · Last updated Jul 01, 2026 · Updated 3 times
Summary
This study tests an experimental drug called ARO-DIMERPA in 78 adults with mixed hyperlipidemia (high cholesterol and triglycerides). The drug is given as a shot under the skin, and researchers are checking if it is safe and how well it lowers fats in the blood. The trial is still in early phases, so the main goal is safety, not yet proving it works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ARO-DIMERPA (an experimental RNA-targeted drug given as a shot under the skin)
What this could lead to
If it works, this could lead to a new treatment option for people with high cholesterol and triglycerides that is easier to take than daily pills.
What could go wrong
This is an early-phase trial with only 78 people, so it is too soon to know if the drug is safe or effective. Side effects are possible, and the drug may not lower cholesterol enough to matter.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA; MIXED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site 1
RECRUITINGChristchurch, 8011, New Zealand
-
Research Site 10
RECRUITINGCalgary, T2N 4N1, Canada
-
Research Site 11
RECRUITINGClayton, 3168, Australia
-
Research Site 2
RECRUITINGAuckland, 622, New Zealand
-
Research Site 3
RECRUITINGAuckland, 2025, New Zealand
-
Research Site 4
RECRUITINGMelbourne, Victoria, 3153, Australia
-
Research Site 5
RECRUITINGMorayfield, Queensland, 4506, Australia
-
Research Site 6
RECRUITINGGrafton, Auckland, 1023, New Zealand
-
Research Site 7
RECRUITINGCharlestown, New South Wales, 2290, Australia
-
Research Site 8
RECRUITINGEast Melbourne, Victoria, 3002, Australia
-
Research Site 9
RECRUITINGPerth, Western Australia, 6009, Australia